These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14644030)

  • 1. Cannabinoids and opioids share cAMP pathway in rat splenocytes.
    Massi P; Vaccani A; Rubino T; Parolaro D
    J Neuroimmunol; 2003 Dec; 145(1-2):46-54. PubMed ID: 14644030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.
    Viganò D; Rubino T; Vaccani A; Bianchessi S; Marmorato P; Castiglioni C; Parolaro D
    Psychopharmacology (Berl); 2005 Nov; 182(4):527-36. PubMed ID: 16079992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound.
    Patrini G; Sacerdote P; Fuzio D; Manfredi B; Parolaro D
    J Neuroimmunol; 1997 Dec; 80(1-2):143-8. PubMed ID: 9413270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
    Rubino T; Viganò D; Massi P; Parolaro D
    J Neurochem; 2000 Nov; 75(5):2080-6. PubMed ID: 11032897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.
    Massi P; Patrini G; Rubino T; Fuzio D; Parolaro D
    Pharmacol Biochem Behav; 1997 Sep; 58(1):73-8. PubMed ID: 9264073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects.
    Massi P; Vaccani A; Romorini S; Parolaro D
    J Neuroimmunol; 2001 Jul; 117(1-2):116-24. PubMed ID: 11431011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
    Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
    Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
    Welch SP; Thomas C; Patrick GS
    J Pharmacol Exp Ther; 1995 Jan; 272(1):310-21. PubMed ID: 7815346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cAMP involvement in cannabinoid-induced antinociception.
    Cook SA; Welch SP; Lichtman AH; Martin BR
    Life Sci; 1995; 56(23-24):2049-56. PubMed ID: 7776831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.
    Herring AC; Koh WS; Kaminski NE
    Biochem Pharmacol; 1998 Apr; 55(7):1013-23. PubMed ID: 9605425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
    Norwood CS; Cornish JL; Mallet PE; McGregor IS
    Eur J Pharmacol; 2003 Mar; 465(1-2):105-14. PubMed ID: 12650839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation.
    Shapira M; Gafni M; Sarne Y
    Brain Res; 2003 Jan; 960(1-2):190-200. PubMed ID: 12505672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice.
    Shafaroodi H; Samini M; Moezi L; Homayoun H; Sadeghipour H; Tavakoli S; Hajrasouliha AR; Dehpour AR
    Neuropharmacology; 2004 Sep; 47(3):390-400. PubMed ID: 15275828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
    Kaminski NE; Abood ME; Kessler FK; Martin BR; Schatz AR
    Mol Pharmacol; 1992 Nov; 42(5):736-42. PubMed ID: 1279376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells.
    Shapira M; Gafni M; Sarne Y
    Brain Res; 1998 Sep; 806(1):26-35. PubMed ID: 9739102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular basis of cannabinoid and opioid interactions.
    Viganò D; Rubino T; Parolaro D
    Pharmacol Biochem Behav; 2005 Jun; 81(2):360-8. PubMed ID: 15927245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain.
    Viganò D; Grazia Cascio M; Rubino T; Fezza F; Vaccani A; Di Marzo V; Parolaro D
    Neuropsychopharmacology; 2003 Jun; 28(6):1160-7. PubMed ID: 12637958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.